Ocugen, Inc. (OCGN)
1.475
+0.02
(+1.37%)
USD |
NASDAQ |
May 07, 10:44
Ocugen Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| REGENXBIO, Inc. | 37.54M |
| Sarepta Therapeutics, Inc. | 96.21M |
| Krystal Biotech, Inc. | -63.58M |
| Phathom Pharmaceuticals, Inc. | -0.061M |
| Catalyst Pharmaceuticals, Inc. | -0.032M |
Cash from Investing (Quarterly) Related Metrics
| Free Cash Flow | -57.15M |
| Free Cash Flow Per Share (Quarterly) | -0.0448 |
| Free Cash Flow to Equity (Quarterly) | -14.18M |
| Free Cash Flow to Firm (Quarterly) | -12.66M |
| Free Cash Flow Yield | -12.61% |